Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18,075Revenue $M7,143Net Margin (%)-1.7Z-Score0.7
Enterprise Value $M22,098EPS $-0.1Operating Margin %1.7F-Score6
P/E(ttm))0Cash Flow Per Share $1.5Pre-tax Margin (%)-3.1Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %0Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %0Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow3.8y-y EBITDA Growth Rate %0ROA % (ttm)-0.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-1.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,343ROI % (ttm)-9.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 13.514%Add 17.65%2,000,000
BSXRay Dalio 2013-12-31 Buy 0.01%$11.18 - $12.38
($11.81)
$ 13.514%New holding, 123584 sh.123,584
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 13.514%Reduce -36.64%8,533,099
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 13.514%Reduce -22.34%45,938,468
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 13.514%Sold Out0
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 13.525%Reduce -18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 13.525%Reduce -27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 13.525%Reduce -15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 13.525%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 13.525%Reduce -69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 13.559%Reduce -96.31%624,088
BSXDodge & Cox 2013-06-30 Reduce-0.14%$7.09 - $9.64
($8.48)
$ 13.559%Reduce -14.79%81,801,130
BSXJoel Greenblatt 2013-06-30 Reduce-0.03%$7.09 - $9.64
($8.48)
$ 13.559%Reduce -51.28%60,894
BSXLeon Cooperman 2013-03-31 Add0.24%$5.73 - $7.81
($7.12)
$ 13.590%Add 13.43%16,473,300
BSXJoel Greenblatt 2013-03-31 Reduce-0.01%$5.73 - $7.81
($7.12)
$ 13.590%Reduce -20.11%124,980
BSXRay Dalio 2013-03-31 Sold Out -0.0025%$5.73 - $7.81
($7.12)
$ 13.590%Sold Out0
BSXMichael Price 2012-12-31 Add0.16%$5.07 - $5.82
($5.49)
$ 13.5146%Add 13.33%1,700,000
BSXMario Gabelli 2012-12-31 Add0.02%$5.07 - $5.82
($5.49)
$ 13.5146%Add 20.63%2,418,305
BSXRay Dalio 2012-12-31 Reduce$5.07 - $5.82
($5.49)
$ 13.5146%Reduce -22.61%42,784
BSXMichael Price 2012-09-30 Add0.78%$4.99 - $5.82
($5.52)
$ 13.5145%Add 149.46%1,500,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BSX Ray Dalio 2013-12-31123,5840.010.01New Buy
BSX Michael Price 2013-12-312,000,0000.153.1+17.65%
BSX PRIMECAP Management 2013-12-3148,405,2193.60.7-0.53%
BSX Mario Gabelli 2013-12-312,201,3050.160.14-1.5%
BSX Vanguard Health Care Fund 2013-12-3136,787,0002.741.4-3.8%
BSX Dodge & Cox 2013-12-3145,938,4683.420.58-22.34%
BSX Leon Cooperman 2013-12-318,533,0990.641.5-36.64%
BSX Joel Greenblatt 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phalen Michael P.EVP & President, MedSurg 2014-04-15Sell13,500$13.253.02view
MARIO ERNESTDirector 2014-04-01Sell10,000$13.550.74view
Phalen Michael P.EVP & President, MedSurg 2014-03-17Sell13,500$13.054.6view
Pierce David ASVP and President, Endoscopy 2014-03-06Sell5,316$13.441.56view
Phalen Michael P.EVP & President, MedSurg 2014-03-06Sell7,281$13.441.56view
Pierce David ASVP and President, Endoscopy 2014-03-03Sell4,829$12.975.24view
Phalen Michael P.EVP & President, MedSurg 2014-03-03Sell3,362$12.975.24view
MARIO ERNESTDirector 2014-03-03Sell10,000$12.985.16view
Lance Jean FittererSVP & Chief Compliance Officer 2014-02-28Sell10,000$13.23.41view
Pierce David ASVP and President, Endoscopy 2014-02-27Sell2,057$13.292.71view

Press Releases about BSX :

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
Diamond Hill Capital Comments on Boston Scientific Corp Jan 15 2014 
Vanguard Health Care Fund Selling Update Oct 30 2013 
Diamond Hill Funds Q3 Market Review and Large-Cap Fund Commentary Oct 29 2013 
Weekly CFO Sells Highlight: BSX, RKUS, MCRL, LRAD and SWKS Sep 08 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
comment on BSX May 22 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Three Key Forces That Drive up Stock Prices Mar 25 2013 
comment on BSX Feb 03 2013 
Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012 

More From Our Partners
Injunction Lifted on Boston Scientific's Guidezilla - Analyst Blog Apr 16 2014 - ZACKS

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide